Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity.
Authors
Frazão, J MMessa, P
Mellotte, G J
Geiger, H
Hagen, E C
Quarles, L D
Kerr, P G
Baños, A
Dehmel, B
Urena, P
Affiliation
School of Medicine, Porto University, Porto, Portugal. jmmdfrazao@netcabo.ptIssue Date
2011-09MeSH
AdultAged
Aged, 80 and over
Calcimimetic Agents
Calcium
Female
Humans
Hyperparathyroidism, Secondary
Male
Middle Aged
Naphthalenes
Parathyroid Hormone
Phosphates
Randomized Controlled Trials as Topic
Young Adult
Metadata
Show full item recordCitation
Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity. 2011, 76 (3):233-43 Clin. Nephrol.Journal
Clinical nephrologyPubMed ID
21888861Abstract
To evaluate the relationship between the severity of secondary hyperparathyroidism (SHPT) - defined in terms of baseline plasma intact parathyroid hormone (iPTH) level - and the magnitude of response to cinacalcet.Item Type
ArticleLanguage
enISSN
0301-0430Collections
Related articles
- [Retrospective assessment of effective and safety of cinacalcet for the treatment of secondary hyperparathyroidism depending on basal iPTH level].
- Authors: Mercadal Orfila G, Blasco Mascaró I
- Issue date: 2012 Jan-Feb
- Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B).
- Authors: Debelle F, Meeus G, Dratwa M, Maes B, Vanholder R, Albert A, Schutyser E, Jadoul M
- Issue date: 2013 Jul-Aug
- [German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)].
- Authors: Reichel H, Braun J
- Issue date: 2011 Jan
- A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
- Authors: Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, Mix TC, Kubo Y, Block GA
- Issue date: 2009 Feb
- Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.
- Authors: Wilkie M, Pontoriero G, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Zani VJ, Carter D, Messa P
- Issue date: 2009